In a variety of tumor mouse models, including antibody -
resistant tumor models, the antibody - IFN therapy was more effective than antibody therapy alone.
Not exact matches
Again, using mouse
models of glioblastoma — this time created from brain
tumor cells that were
resistant to the herpes virus — the therapy led to increased animal survival.
«We hope that our mouse
model, which allows us to combine drug testing and genetic analysis, will provide a deeper understanding of why
tumors are sensitive or
resistant to drugs,» states Ian Frew.
The mice are particularly good
models of estrogen receptor - positive
tumors (so named because they are fueled by estrogen) that have become
resistant to the drugs used to treat them.
These inhibitors effectively targeted and blocked Msi expressing cells, resulting in halted
tumor growth in animal
models as well as in patient - derived cancer cells, which harbor more complex mutations and are uniformly drug -
resistant.
In mouse
models of cancer, targeted therapeutic inhibition of translation disrupts this survival response, dramatically slowing
tumor growth and potentially rendering drug -
resistant tumors vulnerable to other therapies.
Here, we show that ICB increased
tumor vessel perfusion in treatment - sensitive EO771 and MMTV - PyVT breast
tumor as well as CT26 and MCA38 colon
tumor models, but not in treatment -
resistant MCaP0008 and 4T1 breast
tumor models.